TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05909488: Role of Umbilical Cord-derived Stem Cell Transplantation and Conditioned Medium to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II

Sponsor: PT. Prodia Stem Cell Indonesia · Phase: PHASE2/PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,885,680

Rescue Site Savings

+$4,536,448

Unlock Full NCT05909488 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05909488 Rescue Dossier →